Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1MOLGRAMOSTIM[1] Molgramostim (Molgramostim)[1] Molgramostim (Molgramostim) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[2] 229, 299 💬
2Molgramostim 300 mcg nebuliser solution[1] Molgramostim (Molgramostim)[1] Molgramostim (Molgramostim) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 229 💬
3Molgramostim 300 µg nebulizer solution[1] Molgramostim (Molgramostim)[1] Molgramostim (Molgramostim) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 229 💬
4Molgramostim Nebuliser solution 300 mcg[1] Molgramostim (Molgramostim)[1] Molgramostim (Molgramostim) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 229 💬
5Molgramostim nebulizer solution[1] Molgramostim (Molgramostim)[1] Molgramostim (Molgramostim) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[2] 229, 299 💬
6Molgramostim Open-label[1] Molgramostim (Molgramostim)[1] Molgramostim (Molgramostim) 💬 [1] CSF2RA 💬 [4] Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer 💬[1] 229 💬
7RepomolPharmaceutical Form: Solution for infusionINN or Proposed INN: MolgramostimCAS Number: 99283-10-0Concentration unit: µg/ml microgram(s)/millilitreConcentration type: equalConcentration number: 250-----[1] 97 💬